Early signs of liver failure after low-dose interferon alfa-2b for cutaneous melanoma.
Ammoury
Alfred
A
El Sayed
Fouad
F
Farah
Caroline
C
Bazex
Jacques
J
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D017093:Liver Failure / Q000139:chemically induced* / Q000175:diagnosis*; D008545:Melanoma / Q000188:drug therapy*; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins